Shelby Derene Reed, PhD

Professor in Medicine
Member of the Duke Cancer Institute
Member in the Duke Clinical Research Institute
Campus mail Duke Box 17969, #6044 North Pavilion, Durham, NC 27715
Phone (919) 668-8991
Email address shelby.reed@duke.edu

Shelby D. Reed, PhD, is a professor in medicine at the Duke University School of Medicine. She works primarily at the Duke Clinical Research Institute. Dr. Reed holds a PhD in pharmaceutical health services research from the University of Maryland School of Pharmacy and completed a 2-year postdoctoral fellowship in the Pharmaceutical Outcomes Research and Policy Program and the Center for AIDS Research at the University of Washington. Dr. Reed has nearly 20 years of experience in economic evaluation, health services research and health policy. Dr. Reed has extensive expertise in designing and conducting trial-based and model-based cost-effectiveness analyses of medical diagnostics and interventions in numerous therapeutic areas. She was a member of the ISPOR Task Forces that published recommendations for Good Research Practices for Cost-Effectiveness Analysis Alongside Clinical Trials in 2005 and 2015. She has led a wide range of economic and epidemiological studies using secondary data from health care claims, clinical trials, surveys and disease registries. In her evaluations of health policy issues, she has developed computer models to analyze the potential economic impact of trends in clinical trial design, changes in reimbursement policies, financial incentives and the regulatory process in the development of orphan drugs, and the societal value of alternative approaches to identifying drug safety problems. 

Education and Training

  • Ph.D., University of Maryland, College Park, 1998

Publications

Kelleher, SA, Dorfman, CS, Plumb Vilardaga, JC, Majestic, C, Winger, J, Gandhi, V, Nunez, C, Van Denburg, A, Shelby, RA, Reed, SD, Murphy, S, Davidian, M, Laber, EB, Kimmick, GG, Westbrook, KW, Abernethy, AP, and Somers, TJ. "Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART." Contemporary clinical trials 57 (June 2017): 51-57.

PMID
28408335
Full Text

Fairchild, AO, Reed, SD, Johnson, FR, Anglin, G, Wolka, AM, and Noel, RA. "What is clearance worth? Patients' stated risk tolerance for psoriasis treatments." The Journal of dermatological treatment (June 2017): 1-7.

PMID
28494683
Full Text

Streufert, B, Reed, SD, Orlando, LA, Taylor, DC, Huber, JC, and Mather, RC. "Understanding Preferences for Treatment After Hypothetical First-Time Anterior Shoulder Dislocation: Surveying an Online Panel Utilizing a Novel Shared Decision-Making Tool." Orthopaedic journal of sports medicine 5, no. 3 (March 20, 2017): 2325967117695788-.

PMID
28377932
Full Text

Thaden, JT, Li, Y, Ruffin, F, Maskarinec, SA, Hill-Rorie, JM, Wanda, LC, Reed, SD, and Fowler, VG. "Increased Costs Associated with Bloodstream Infections Caused by Multidrug-Resistant Gram-Negative Bacteria Are Due Primarily to Patients with Hospital-Acquired Infections." Antimicrobial agents and chemotherapy 61, no. 3 (March 2017).

PMID
27993852
Full Text

Levy, WC, Li, Y, Reed, SD, Zile, MR, Shadman, R, Dardas, T, Whellan, DJ, Schulman, KA, Ellis, SJ, Neilson, M, O'Connor, CM, and HFACTION Investigators, . "Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?." JACC. Clinical electrophysiology 3, no. 3 (March 2017): 291-298.

PMID
28553663
Full Text

Reeves, GR, Whellan, DJ, Duncan, P, O'Connor, CM, Pastva, AM, Eggebeen, JD, Hewston, LA, Morgan, TM, Reed, SD, Rejeski, WJ, Mentz, RJ, Rosenberg, PB, Kitzman, DW, and REHAB-HF Trial Investigators, . "Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale." American heart journal 185 (March 2017): 130-139.

PMID
28267466
Full Text

Adam, MA, Thomas, S, Youngwirth, L, Hyslop, T, Reed, SD, Scheri, RP, Roman, SA, and Sosa, JA. "Is There a Minimum Number of Thyroidectomies a Surgeon Should Perform to Optimize Patient Outcomes?." Annals of surgery 265, no. 2 (February 2017): 402-407.

PMID
28059969
Full Text

Foote, JR, Lopez-Acevedo, M, Buchanan, AH, Secord, AA, Lee, PS, Fountain, C, Myers, ER, Cohn, DE, Reed, SD, and Havrilesky, LJ. "Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer." Journal of Oncology Practice 13, no. 2 (February 2017): e120-e129.

Full Text

Foote, JR, Lopez-Acevedo, M, Buchanan, AH, Secord, AA, Lee, PS, Fountain, C, Myers, ER, Cohn, DE, Reed, SD, and Havrilesky, LJ. "Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer." Journal of oncology practice (January 3, 2017): JOP2016011866-.

PMID
28045615
Scholars@Duke

Reed, SD, Faulkner, E, and Veenstra, DL. "Developing the Value Proposition for Personalized Medicine." In Genomic and Precision Medicine: Foundations, Translation, and Implementation: Third Edition, 327-342. December 15, 2016.

Full Text

Pages